Amy K. Goodwin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amy K. Goodwin has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Merle G. Paule
Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, United States
2 shared publicationsTakato Hiranita
Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, United States
2 shared publicationsJennifer E. Naylor
Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, United States
1 shared publicationKatelin S. Matazel
Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, United States
1 shared publicationXuan Zhang
Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, United States
1 shared publication
Latest Publications
- 1 October 2017
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 179, 254-259
Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride
- 1 October 2017
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 179, 254-259
Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride
- 1 November 2016
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 82, 31-36
An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates
- 1 November 2016
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 82, 31-36
An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates
- 10 February 2015
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 17 (11) , 1297-1310
The Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research
Introduction: Cigarette smoking is largely driven by the reinforcing properties of nicotine. Intravenous (IV) self-administration procedures are the gold standard for investigating the reinforcing effects of psychoactive drugs. The goal of this review was to examine the results of published investigations of the reinforcing effects of nicotine measured using IV self-administration procedures in humans and nonhuman primates. Results: The body of literature using nonhuman primate subjects indicates nicotine functions as a positive reinforcer when available for self-administration via IV catheters. However, it can also be difficult to establish IV nicotine self-administration in nonhuman primates and sometimes supplemental strategies have been required (e.g., priming injections or food deprivation) before subjects acquire the behavior. Although the body of literature using human subjects is limited, the evidence indicates nicotine functions as a reinforcer via the IV route of administration in adult cigarette smokers. Rates of nicotine self-injection can be variable across subjects and responding is sometimes inconsistent across sessions in both humans and nonhuman primates. Conclusions: The Family Smoking Prevention and Tobacco Control Act, enacted in 2009, gave the Food and Drug Administration regulatory authority over the manufacture, marketing, and distribution of tobacco products. Research examining the threshold reinforcing doses for initiation and maintenance of nicotine self-administration, comparisons of the reinforcing effects of nicotine in adolescent versus adult subjects, investigations of gender differences in the reinforcing effects of nicotine, and studies of the abuse liability of non-nicotine tobacco product constituents and their ability to alter the reinforcing effects of nicotine will inform potential tobacco regulatory actions.
- 10 February 2015
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 17 (11) , 1297-1310
The Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research
Introduction: Cigarette smoking is largely driven by the reinforcing properties of nicotine. Intravenous (IV) self-administration procedures are the gold standard for investigating the reinforcing effects of psychoactive drugs. The goal of this review was to examine the results of published investigations of the reinforcing effects of nicotine measured using IV self-administration procedures in humans and nonhuman primates. Results: The body of literature using nonhuman primate subjects indicates nicotine functions as a positive reinforcer when available for self-administration via IV catheters. However, it can also be difficult to establish IV nicotine self-administration in nonhuman primates and sometimes supplemental strategies have been required (e.g., priming injections or food deprivation) before subjects acquire the behavior. Although the body of literature using human subjects is limited, the evidence indicates nicotine functions as a reinforcer via the IV route of administration in adult cigarette smokers. Rates of nicotine self-injection can be variable across subjects and responding is sometimes inconsistent across sessions in both humans and nonhuman primates. Conclusions: The Family Smoking Prevention and Tobacco Control Act, enacted in 2009, gave the Food and Drug Administration regulatory authority over the manufacture, marketing, and distribution of tobacco products. Research examining the threshold reinforcing doses for initiation and maintenance of nicotine self-administration, comparisons of the reinforcing effects of nicotine in adolescent versus adult subjects, investigations of gender differences in the reinforcing effects of nicotine, and studies of the abuse liability of non-nicotine tobacco product constituents and their ability to alter the reinforcing effects of nicotine will inform potential tobacco regulatory actions.